11 results
Angiotensin-Converting Enzyme Inhibitors - Inhibit the conversion of AngI to AngII
 • Captopril, Lisinopril, Enalapril, Benazepril,
- Inhibit the conversion ... Direct Renin Inhibitors ... renin and thus the conversion ... #ACEis #ARBs #pharmacology ... #table #medications
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
including tips for using ... dosage forms and conversion ... #pharmacology #antibiotics ... #medications #table
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... #Renal #Dosing ... #Pharmacology #Management ... #Diabetes #DM2 ... #Endocrinology
Angiotensin Receptor Blockers 
Recommended Dose Conversions 

Valsartan 
Irbesartan 
Losartan 
Olmesartan 
Telmisartan 
Candesartan 
Azilsartan 
Eprosartan 

A few
Recommended Dose Conversions ... at-a-glance dose conversion ... cough compared to ACEI's ... #Table #Dosing ... #Pharmacology #Dose
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
partially developing as ... #pharmacology #comparison ... #treatment #medications ... #dosing #drugs ... #table #pharmacotherapy
The 8 A’s — drugs that interact with warfarin
Antibiotics 
 - Most agents, but especially co-trimoxazole,
with warfarin Antibiotics ... Gingko biloba, dong ... #Interactions #Table ... #Mnemonic #8As ... #Pharmacology #Medications
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Diabetes #Mellitus #DM2 ... #pharmacology # ... comparison #table ... #endocrinology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... anti-diabetic medications ... #Pharmacology # ... Medications #DM2 ... #Diabetes #Endocrinology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Phosphodiesterase-4 (PDE4) Inhibitor ... Eosinophils < 100 Dosing ... : 250 mcg tablet ... the use of this medication ... #Pharmacology #
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... semaglutide, the same medication ... drug to remain stable ... semaglutide #Diabetes #Pharmacology ... #Endocrinology